Navigation Links
New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes



AMADEO, a randomized, double-blind, forced-titration, parallel-group, multicentre study, included 860 hypertensive patients ((greater than)130/80mmHg) with type 2 diabetes and overt nephropathy from 124 centres in 10 countries. Patients were randomized to receive treatment with either telmisartan 80mg or losartan 100mg. To ensure blood pressure control in the two patient groups other non- ARB treatments (hydrochlorothiazide or calcium channel blocker) were added, if needed.

After one year's treatment, telmisartan was significantly more effective than losartan in reducing the amount of protein excreted in the urine. The primary end point of the study was reduced by 29% with telmisartan vs. 20% with losartan; p=0.0284(1). Telmisartan was superior to losartan on the primary endpoint, a change from baseline after 12 months (log transformed Urinary Protein creatinine ratio) of 0.71 (95% CI; 0.66, 0.77) vs. 0.80 (95% CI; 0.74,0.87) for losartan; p=0.0284.(1) No significant difference in blood pressure control or number of adverse events was observed between the two treatments groups(1). Proteinuria (high levels of protein in the urine) is a very important signal for disease severity in diabetic nephropathy and is also considered a relevant cardiovascular risk factor. Renal outcomes trials have shown that reductions of (greater than)30% at six months are strongly linked to slowed progression to end-stage kidney disease and reduced cardiovascular events.(6)

AMADEO successfully concludes the series of PROTECTION studies which are part of an extensive ongoing trial programme, including clinical and observational studies, investigating the outstanding effects of telmisartan compared with other treatments for hypertension, including other available ARBs. The trials established the effects of telmisartan in providing powerful blood pressure reductions from morning to morning as well as organ-protective
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/22/2015)... and KING OF PRUSSIA, Pa. ... (NHF) has awarded CSL Behring its 2015 ... unwavering commitment to advancing science and improving the care of ... Paul Perreault , CEO and Managing Director, CSL Limited, during ... City on May 21. "The National ...
(Date:5/22/2015)... DALLAS , May 22, 2015 ... Stress Assay Market by Product (Consumables, Instruments, Services), by ... Technology (ELISA, Chromatography, Flow Cytometry), by End Users - ... Stress Assays Market is expected to reach $736.85 Million ... a CAGR of 10.25%. Browse 71 ...
(Date:5/22/2015)... , May 22, 2015 Research and Markets ... addition of the "Latest Regulations on Pharmaceutical ... to their offering. This is first ... a guidance on international multi-center clinical trials of ... has begun to be implemented on March 1, ...
Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... Company 31st Annual Health Care Conference on Wednesday, March 9, ...   Interested parties may access a live webcast ... http://www.onyx-pharm.com/view.cfm/32/Event-Calendar It is recommended that listeners ...
... March 2, 2011 Men who take non-steroidal anti-inflammatory drugs ... 2.4 times more likely to have erectile dysfunction compared to ... a Kaiser Permanente study published online in The Journal ... a trend toward this same finding, this observational study used ...
Cached Medicine Technology:Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference 2Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 2Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 3
(Date:5/23/2015)... May 23, 2015 Injury lawyer Steven H. ... been passed by the Maryland legislature but which has not ... General Assembly passed HB 449 with overwhelming bipartisan ... not signed it into law. This bill ensures that fracking ... growing that demonstrates the danger of fracking to our water ...
(Date:5/22/2015)... Pioneer Millworks, the largest reclaimed wood ... designing with reclaimed wood, introducing their latest reclaimed wood ... Their newest offerings, Vat 35, Reclaimed Teak , ... to America's largest design event. , “Designers, architects, builders, ... anxious to see and feel the variety of wood ...
(Date:5/22/2015)... Mountain Point Medical Center, a campus of Jordan ... Friday, May 29, 2015 at 11 a.m., followed by a ... medical center, set to officially open on June 1, 2015, ... , “The opening of Mountain Point Medical Center is ... community,” said Kent Loosle, CEO of Mountain Point Medical Center. ...
(Date:5/22/2015)... 22, 2015 Hundreds of federal ... of individuals who allegedly experienced serious internal bleeding ... to move forward in the U.S. District Court, ... Order dated May 4, 2015, the Court has ... electronically stored information. Among other things, the Order ...
(Date:5/22/2015)... Hershey, Pa. (PRWEB) May 22, 2015 ... has been selected to participate in the 2015 Congress ... event is described as a gathering of “America’s highest ... about new areas of healthcare, set new goals and ... will include a live surgery, during which we can ...
Breaking Medicine News(10 mins):Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2
... for Increased Awareness of Disease, Funding for Research, SAN ... of 40,000 people in the U.S. who will lose,their lives ... will die from breast cancer. Yet, most people have never ... has no FDA approved treatment, no known cause and no ...
... BENSALEM, Pa., Oct. 31 Law Offices of Howard ... been filed on behalf,of purchasers of the common stock ... WCG ) between May 8, 2006 and October,24, 2007, ... in the United States District Court for the Middle ...
... Group Uses PETA Talking Points, Discourages Donations to,Legitimate ... health reporters,cover today,s report on global causes of ... nonprofit Center for Consumer Freedom is urging,them to ... animal,rights group calling itself "The Cancer Project." A ...
... Insurers Outline Features of their Countries, Models at,Event Sponsored ... Switzerland and The,Netherlands are among countries in Europe ... private sector plays a central role,in making care better ... countries have taken to cover all of their citizens, ...
... their risk of dying of the disease in half ... their cancer, compared to those who dont receive active ... diagnosed with localized prostate cancer, according to a study ... Therapeutic Radiology and Oncologys 49th Annual Meeting in Los ...
... says exercise and diet can lower chances of malignancies ... exercise and proper nutrition are key to reducing your ... adopt these practices, the better off you,ll be, a ... childbearing, breast-feeding, and adult height and weight also influence ...
Cached Medicine News:Health News:Goulet's Life Lost to Untreatable Lung Disease That Claims as Many Lives as Breast Cancer Each Year 2Health News:Consumer Alert: 'Cancer Project' Organization Is a Deceptive Animal Rights Group 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 3Health News:Radiation seed implant decreases risk of death over watchful waiting 2Health News:Obesity Linked to Increased Cancer Risk 2Health News:Obesity Linked to Increased Cancer Risk 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: